What's Happening

CVS Health's health insurance unit Aetna plans to simplify the prior authorization process for cancer treatment by replacing multiple approvals with one bundled authorization at the beginning of a patient's treatment.

Starting in the first half of 2027, the change will apply across Aetna's commercial insurance plans and Medicare Advantage plans. Aetna began rolling out the bundled approach for Medicaid members in eight states on September 1, 2026. (Reuters)

Under the new system, doctors will submit documentation showing that a patient is receiving cancer treatment. Instead of seeking separate approvals for chemotherapy, radiation, imaging and some immunotherapies, providers can obtain approval for a broader treatment package upfront. (Reuters)

The goal is to reduce paperwork for cancer care teams and make it easier for patients to move through treatment without repeatedly waiting for insurer approval.

What Is Prior Authorization?

Prior authorization is a process insurers use to determine whether certain medical services, procedures or treatments should be covered before care is provided.

For cancer patients, the process can involve multiple types of treatment and diagnostic services.

A patient could need separate authorization for:

  • Chemotherapy
  • Immunotherapy
  • Radiation treatment
  • MRI or CT scans
  • Other specialized imaging
  • Certain related services

Aetna says providers currently submit an average of four separate prior authorizations for each member receiving cancer treatment. (Reuters)

That creates a recurring administrative burden because treatment plans can involve multiple services over an extended period.

How Aetna's New Bundled System Works

Instead of reviewing every component separately, Aetna will allow eligible cancer patients to receive a single upfront authorization covering a broader treatment plan.

Providers will submit the required information through one online portal.

The bundled authorization can include medical oncology services, including chemotherapy and immunotherapy when appropriate, radiation oncology and associated high-tech imaging such as MRI or CT scans. (CVS Health)

This means oncologists can make adjustments to a patient's treatment plan without having to restart the entire authorization process for every individual service within the approved treatment pathway.

Medicaid Rollout Has Already Started

The new model is not entirely a future initiative.

Aetna began using bundled cancer-treatment authorizations for eligible Medicaid members in eight states on September 1, 2026.

Those states are:

  • Oklahoma
  • Illinois
  • Maryland
  • New Jersey
  • Virginia
  • Florida
  • Kentucky
  • West Virginia

The program is available to providers using Aetna's Eviti portal to submit prior authorizations. (CVS Health)

Aetna said nearly 25% of eligible members had already received a bundled authorization during the initial rollout. (CVS Health)

The 2027 Expansion

Aetna plans to expand the bundled authorization model across its businesses during the first half of 2027.

That will include:

  • Commercial Plans: The approach will be available to members covered by Aetna's private health insurance plans.
  • Medicare Advantage: It will also extend to Aetna's Medicare Advantage population, which includes people age 65 and older and certain people with disabilities.

The expansion would make the oncology authorization model relevant to a much larger portion of Aetna's insured population. (Reuters)

Why Cancer Was Chosen

Aetna Chief Operating Officer Katerina Guerraz said cancer was selected because oncology treatment frequently involves repeated imaging.

MRI and CT scans commonly require prior authorization, and cancer patients can undergo multiple scans during their treatment.

That makes oncology particularly suitable for a bundled model because many related services are already connected to a single treatment plan. (Reuters)

Guerraz also pointed to the high and increasing prevalence of cancer as a reason for focusing on the condition.

Administrative Burden Is a Major Provider Concern

The initiative comes as healthcare providers continue to identify administrative work as a significant operational problem.

An Aetna-sponsored provider survey found that 74% of providers identified administrative burden as a top challenge for clinical staff.

Another 31% said prior authorization management was the single largest contributor to that burden. (CVS Health)

That means the issue is not simply paperwork associated with individual patients.

Providers view prior authorization as a broader workflow problem that can consume staff time and take attention away from clinical work.

Potential Time Savings for Providers

Aetna's survey also asked providers how much time technology such as bundled authorization systems could save.

About 30% of respondents said they could save more than one hour per day, while 80% expected to save more than 30 minutes daily on administrative tasks. (CVS Health)

Those figures come from Aetna's provider survey and represent respondents' expectations rather than independently measured time savings from the new oncology program.

Still, they show why insurers and providers are increasingly interested in automating and consolidating authorization processes.

What Changes for Cancer Patients

For patients, the biggest change is potentially fewer administrative interruptions during treatment.

Under the current system, a patient may have a treatment plan approved but still encounter additional authorization requirements for scans or subsequent components of care.

With a bundled authorization, Aetna intends to approve a broader group of services at the beginning of the treatment journey.

That could reduce the number of times a provider has to stop and obtain another insurer decision.

It Does Not Remove Clinical Review Entirely

The new system does not mean Aetna will stop reviewing cancer treatment for medical necessity.

The insurer will still require documentation showing that the patient is receiving cancer treatment and that the requested services fall within the applicable criteria.

The difference is that the review occurs at a broader level rather than through repeated approvals for each individual component.

That distinction allows the insurer to maintain utilization management while reducing the number of administrative steps.

Providers Can Adjust Treatment Plans

One potential benefit of the bundled approach is greater flexibility for oncologists.

Cancer treatment can change based on how a patient responds to therapy, new test results or changes in clinical circumstances.

Aetna says oncologists will have flexibility to make treatment decisions as plans evolve once the broader authorization is in place. (CVS Health)

That could reduce administrative friction when a treatment plan changes within the scope of the approved cancer-care pathway.

The Change Is Part of a Larger Industry Trend

Aetna's initiative is part of a broader effort by health insurers to reduce the burden associated with prior authorization.

In 2025, the industry trade group AHIP announced commitments aimed at reducing the number of services requiring authorization, standardizing electronic submissions and speeding up insurer responses. (Reuters)

Aetna has also been working on other ways of simplifying prior authorization.

In April 2026, the company said it had standardized 88% of its prior authorization volume, with more than 95% of eligible requests approved within 24 hours and 83% processed in real time. (CVS Health)

The cancer bundling initiative is therefore part of a wider operational strategy rather than a standalone change.

UnitedHealthcare and Humana Are Also Reducing Prior Authorizations

Aetna is not the only major insurer changing its approach.

UnitedHealthcare has said it plans to eliminate about 30% of prior authorization requirements across its insurance business.

Humana has pledged to eliminate 33% of prior authorizations for outpatient services. (Reuters)

The changes suggest that prior authorization is becoming an area where major health plans are competing on administrative simplicity as well as traditional insurance benefits.

Aetna May Expand Bundling Beyond Cancer

Aetna has indicated that oncology may be the first of several conditions where it uses bundled authorization.

Guerraz said the company could eventually expand the model to musculoskeletal conditions, including knee and hip problems. (Reuters)

That could create a much broader system in which authorization is organized around a patient's overall episode of care rather than individual services.

Such a model could potentially be applied to other conditions involving multiple connected procedures, tests and treatments.

Why This Matters for Health Systems

Hospitals and cancer centers spend substantial amounts of staff time managing insurer requirements.

A reduction in authorization volume could affect:

  • Staff Workloads: Administrative employees may spend less time preparing repetitive authorization requests.
  • Treatment Scheduling: Fewer pending approvals could simplify scheduling of treatments and imaging.
  • Patient Experience: Patients may face fewer interruptions related to coverage confirmation.
  • Revenue Cycle Operations: Hospitals could reduce delays associated with obtaining authorization before delivering covered care.

The actual impact will depend on how consistently the new process works in practice.

Why This Matters for Insurers

For Aetna, simplifying authorization also has a business rationale.

Technology-enabled authorization can potentially reduce administrative costs while maintaining utilization controls.

A bundled system may also provide the insurer with a more complete view of the patient's treatment episode.

Instead of evaluating isolated requests, Aetna can assess a broader treatment plan at the beginning of care.

That could help align utilization management more closely with the way oncology care is actually delivered.

Why Cancer Care Is a Complex Administrative Category

Cancer treatment often involves several specialties working together.

A patient may interact with medical oncology, radiation oncology, radiology, pathology, surgery and other specialists.

Different services can fall under different authorization requirements.

That complexity makes oncology particularly vulnerable to repetitive administrative processes.

A bundled approach attempts to account for that interconnectedness.

The Role of Digital Infrastructure

Aetna's approach depends heavily on a digital workflow.

Providers submit requests through a single online portal, and the bundled authorization connects multiple services within the patient's cancer-care pathway. (CVS Health)

This is another example of healthcare administration shifting from paper and fragmented processes toward integrated digital systems.

The broader direction is toward systems that can automatically connect patient information, clinical documentation, treatment plans, insurer rules and authorization decisions.

That creates opportunities for healthcare technology companies working in administrative automation.

Potential Challenges

Bundled authorization also raises questions about implementation.

Cancer treatment is not identical for every patient.

Treatment plans can change, and some services may fall outside the original scope of an authorization.

The system will therefore need clear rules governing what is included, when additional approval is still required and how quickly exceptions can be processed.

The quality of the underlying digital infrastructure will also matter.

If documentation requirements remain complicated despite the bundling, providers may see less benefit than expected.

Why This Matters

Aetna's cancer initiative is significant because it changes the unit of prior authorization from individual services toward the broader cancer-treatment episode.

The company says its members undergoing cancer treatment currently require about four separate authorizations on average, while the new system aims to consolidate those requests into one upfront process. (Reuters)

If the model works as intended, it could reduce repetitive paperwork for oncology teams and make treatment planning more predictable for patients.

It also reflects a wider shift among health insurers toward simplifying administrative processes through technology and bundled workflows.

Looking Ahead

Aetna's Medicaid rollout is already underway in eight states, while the company plans to expand the model across its commercial and Medicare Advantage businesses in the first half of 2027. (CVS Health)

The company has also indicated that it may eventually apply bundled authorizations to musculoskeletal conditions.

The important measures will be whether the new system actually reduces provider workload, shortens authorization processing times and limits interruptions to cancer treatment.

The broader industry trend will also be important to watch as other insurers continue modifying their prior authorization policies.

Key Takeaways

  • Aetna will reduce cancer-treatment prior authorizations to one bundled authorization at the beginning of treatment. (Reuters)
  • The new system will replace separate approvals for services such as chemotherapy, radiation, imaging and some immunotherapies. (Reuters)
  • The change began for eligible Medicaid members in eight states on September 1, 2026. (CVS Health)
  • Aetna plans to expand the model to commercial and Medicare Advantage plans in the first half of 2027. (Reuters)
  • Providers currently submit an average of four prior authorizations per Aetna cancer patient during treatment. (Reuters)
  • Nearly 25% of eligible Medicaid members had already received a bundled authorization during the initial rollout. (CVS Health)
  • An Aetna survey found 74% of providers identified administrative burden as a top challenge, while 31% identified prior authorization management as the largest contributor. (CVS Health)
  • Aetna plans to potentially extend bundled authorization to musculoskeletal conditions such as knee and hip problems. (Reuters)
  • UnitedHealthcare has said it plans to eliminate about 30% of prior authorization requirements, while Humana has pledged to eliminate 33% of outpatient prior authorizations. (Reuters)
  • Aetna's broader prior-authorization program had already standardized 88% of its prior authorization volume by April 2026. (CVS Health)

What This Means for Healthcare Marketers

For healthcare marketers, Aetna's move highlights how administrative friction can become a healthcare product and technology opportunity.

Health systems and providers are increasingly looking for solutions that reduce time spent on authorizations, claims, documentation and other administrative tasks.

For companies selling healthcare technology or services, signals such as payer policy changes, provider complaints about administrative burden, digital portal adoption and insurer investment in automation can indicate where organizations are actively looking for operational improvements.

The shift also suggests that healthcare buyers may increasingly evaluate solutions based not only on clinical functionality but on how much administrative work they remove from frontline teams.